- Report
- November 2026
Global
From €450EUR$513USD£389GBP
- Report
- March 2025
- 84 Pages
Global
From €400EUR$456USD£345GBP
- Report
- March 2022
- 553 Pages
Global
From €2450EUR$2,791USD£2,115GBP
- Report
- October 2025
- 130 Pages
Global
From €3104EUR$3,300USD£2,589GBP
- Report
- September 2025
- 220 Pages
Global
From €2822EUR$3,000USD£2,354GBP
- Report
- March 2025
- 130 Pages
Global
From €3104EUR$3,300USD£2,589GBP
- Report
- November 2023
- 1800 Pages
Global
From €4797EUR$5,100USD£4,001GBP
- Report
- June 2023
- 840 Pages
Global
From €3386EUR$3,600USD£2,824GBP
- Report
- December 2020
- 120 Pages
Global
From €1881EUR$2,000USD£1,569GBP
- Report
- October 2020
- 222 Pages
Global
From €2822EUR$3,000USD£2,354GBP
- Clinical Trials
- August 2020
- 300 Pages
Global
From €2822EUR$3,000USD£2,354GBP
- Report
- September 2019
- 75 Pages
United States
From €1881EUR$2,000USD£1,569GBP
- Report
- March 2018
- 255 Pages
Global
From €2445EUR$2,600USD£2,040GBP
- Report
- June 2023
- 218 Pages
Global
From €4901EUR$5,393USD£3,950GBP
- Drug Pipelines
- May 2025
- 150 Pages
Global
From €3104EUR$3,300USD£2,589GBP
- Report
- November 2024
- 239 Pages
Global
From €3927EUR$4,175USD£3,276GBP
- Report
- March 2025
- 170 Pages
Global
From €4513EUR$4,799USD£3,765GBP
- Report
- December 2023
- 110 Pages
Global
From €4513EUR$4,799USD£3,765GBP
- Report
- June 2021
- 193 Pages
Global
From €4513EUR$4,799USD£3,765GBP
- Report
- March 2020
- 137 Pages
Global
From €4608EUR$4,899USD£3,844GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more